» Articles » PMID: 24056061

Induced Pluripotency for Translational Research

Overview
Specialty Biology
Date 2013 Sep 24
PMID 24056061
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The advent of induced pluripotent stem cells (iPSCs) has revolutionized the concept of cellular reprogramming and potentially will solve the immunological compatibility issues that have so far hindered the application of human pluripotent stem cells in regenerative medicine. Recent findings showed that pluripotency is defined by a state of balanced lineage potency, which can be artificially instated through various procedures, including the conventional Yamanaka strategy. As a type of pluripotent stem cell, iPSCs are subject to the usual concerns over purity of differentiated derivatives and risks of tumor formation when used for cell-based therapy, though they provide certain advantages in translational research, especially in the areas of personalized medicine, disease modeling and drug screening. iPSC-based technology, human embryonic stem cells (hESCs) and direct lineage conversion each will play distinct roles in specific aspects of translational medicine, and continue yielding surprises for scientists and the public.

Citing Articles

Mutations in voltage-gated L-type calcium channel: implications in cardiac arrhythmia.

Zhang Q, Chen J, Qin Y, Wang J, Zhou L Channels (Austin). 2018; 12(1):201-218.

PMID: 30027834 PMC: 6104696. DOI: 10.1080/19336950.2018.1499368.


Translational Prospects and Challenges in Human Induced Pluripotent Stem Cell Research in Drug Discovery.

Hosoya M, Czysz K Cells. 2016; 5(4).

PMID: 28009813 PMC: 5187530. DOI: 10.3390/cells5040046.


Systematic optimization of human pluripotent stem cells media using Design of Experiments.

Marinho P, Chailangkarn T, Muotri A Sci Rep. 2015; 5:9834.

PMID: 25940691 PMC: 4419516. DOI: 10.1038/srep09834.


Survival and migration of pre-induced adult human peripheral blood mononuclear cells in retinal degeneration slow (rds) mice three months after subretinal transplantation.

Peng Y, Zhang Y, Huang B, Luo Y, Zhang M, Li K Curr Stem Cell Res Ther. 2013; 9(2):124-33.

PMID: 24350910 PMC: 4101734. DOI: 10.2174/1574888x09666131219115125.

References
1.
Chae J, Kim D, Lee N, Jeon Y, Jeon I, Kwon J . Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J. 2012; 446(3):359-71. DOI: 10.1042/BJ20111495. View

2.
Hanna J, Wernig M, Markoulaki S, Sun C, Meissner A, Cassady J . Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. 2007; 318(5858):1920-3. DOI: 10.1126/science.1152092. View

3.
Hu B, Zhang S . Differentiation of spinal motor neurons from pluripotent human stem cells. Nat Protoc. 2009; 4(9):1295-304. PMC: 2789120. DOI: 10.1038/nprot.2009.127. View

4.
Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y . Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell. 2013; 12(4):487-96. DOI: 10.1016/j.stem.2013.01.009. View

5.
Briggs R, King T . Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs. Proc Natl Acad Sci U S A. 1952; 38(5):455-63. PMC: 1063586. DOI: 10.1073/pnas.38.5.455. View